4 Podcast Episodes
#59 - Hartmut Ehrlich: CEO of Abivax
#59 - Hartmut Ehrlich: CEO of Abivax
Hartmut Ehrlich, CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and ho... Read more
22 Apr 2023
•
50mins
Hartmut Ehrlich and Philippe Pouletty discuss Abivax Clinical Programs Involving Covid-19 and more.
Hartmut Ehrlich and Philippe Pouletty discuss Abivax Clinical Programs Involving Covid-19 and more.
Hartmut Ehrlich and Philippe Pouletty discuss Abivax Pipeline of Clinical Programs involving Covid-19, Ulcerative Coliti... Read more
9 Dec 2020
•
33mins
Novel Anti-Inflammatory Therapeutic Agent Showing Promise for Ulcerative Colitis with Dr. Hartmut Ehrlich Abivax
Novel Anti-Inflammatory Therapeutic Agent Showing Promise for Ulcerative Colitis with Dr. Hartmut Ehrlich Abivax
Dr. Hartmut Ehrlich, CEO, Abivax gives an update of the French biotech's phase-2b clinical trial drug candidate ABX464 ... Read more
24 Mar 2020
•
19mins
Drug Moves From Antiviral to Treating Inflammatory Diseases with Dr. Hartmut Ehrlich Abivax
Drug Moves From Antiviral to Treating Inflammatory Diseases with Dr. Hartmut Ehrlich Abivax
Dr. Hartmut Ehrlich, CEO of Abivax discusses the exciting new progress that this French biotechnology company has observ... Read more
8 Apr 2019
•
17mins